Evidence map›Paper›PMID 42198289›Full record

ArticlePharmaceutics2026

Type 2 Diabetes Modulates Mesenchymal Stem Cell Response to Advanced Glycation End Products and N-Acetylcysteine Antioxidant Effect.

Rebecca Landon, Ji Ding, William Ndjidda Bakari, Nathanael Larochette, Hanane El-Hafci, Olivier Thibaudeau, Abolfazl Barzegari, Virginie Gueguen, Graciela Pavon-Djavid, Fani Anagnostou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rebecca LandonUniversité Paris Cité, CNRS UMR7052, INSERM U1271, ENVA, B3OA, F-75010 Paris, France.ORCID 0000-0002-6827-9437
Ji DingUniversité Paris Cité, CNRS UMR7052, INSERM U1271, ENVA, B3OA, F-75010 Paris, France.
William Ndjidda BakariUniversité Paris Cité, CNRS UMR7052, INSERM U1271, ENVA, B3OA, F-75010 Paris, France.ORCID 0000-0003-4986-7126
Nathanael LarochetteUniversité Paris Cité, CNRS UMR7052, INSERM U1271, ENVA, B3OA, F-75010 Paris, France.ORCID 0000-0002-7936-678X
Hanane El-HafciUniversité Paris Cité, CNRS UMR7052, INSERM U1271, ENVA, B3OA, F-75010 Paris, France.
Olivier ThibaudeauHôpital Bichat-Claude-Bernard, Plateau de Morphologie UMR 1152, Université Paris Cité, F-75018 Paris, France.
Abolfazl BarzegariLaboratory for Vascular Translational Science (LVTS), Cardiovascular Bioengineering, Université Sorbonne Paris Nord, Inserm U1148, F-93430 Villetaneuse, France.
Virginie GueguenLaboratory for Vascular Translational Science (LVTS), Cardiovascular Bioengineering, Université Sorbonne Paris Nord, Inserm U1148, F-93430 Villetaneuse, France.ORCID 0000-0003-2500-0747
Graciela Pavon-DjavidLaboratory for Vascular Translational Science (LVTS), Cardiovascular Bioengineering, Université Sorbonne Paris Nord, Inserm U1148, F-93430 Villetaneuse, France.ORCID 0000-0001-5819-1071
Fani AnagnostouUniversité Paris Cité, CNRS UMR7052, INSERM U1271, ENVA, B3OA, F-75010 Paris, France.

Funding

Contrat doctoral MESR Université de Paris-Cité Rebecca LandonFondation de l'Avenir AP-RM-23-017National Agency for Research ANR-24-CE19-3040-02
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced glycated end-products (AGEs)antioxidantbone marrowbone marrow mesenchymal stem cells (BMMSCs)diabetesmesenchymal stem cellN-acetylcysteine (NAC)

Identifiers

PMID42198289
PMCPMC13210573

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.